IT1283911B1 - Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo - Google Patents

Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo

Info

Publication number
IT1283911B1
IT1283911B1 IT96RM000075A ITRM960075A IT1283911B1 IT 1283911 B1 IT1283911 B1 IT 1283911B1 IT 96RM000075 A IT96RM000075 A IT 96RM000075A IT RM960075 A ITRM960075 A IT RM960075A IT 1283911 B1 IT1283911 B1 IT 1283911B1
Authority
IT
Italy
Prior art keywords
pct
ophthalmic
date aug
sec
concentrations
Prior art date
Application number
IT96RM000075A
Other languages
English (en)
Inventor
Marco Fabrizio Saettone
Susi Burgalassi
Boris Giannaccini
Enrico Boldrini
Pietro Bianchini
Giulio Luciani
Original Assignee
Farmigea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea Spa filed Critical Farmigea Spa
Publication of ITRM960075A0 publication Critical patent/ITRM960075A0/it
Priority to IT96RM000075A priority Critical patent/IT1283911B1/it
Priority to DK97902574T priority patent/DK0892636T3/da
Priority to EA199800689A priority patent/EA001067B1/ru
Priority to PT97902574T priority patent/PT892636E/pt
Priority to DE69706410T priority patent/DE69706410T2/de
Priority to ES97902574T priority patent/ES2164327T3/es
Priority to PCT/IT1997/000026 priority patent/WO1997028787A1/en
Priority to AU16178/97A priority patent/AU1617897A/en
Priority to JP52835697A priority patent/JP3872515B2/ja
Priority to KR10-1998-0705973A priority patent/KR100430260B1/ko
Priority to EP97902574A priority patent/EP0892636B1/en
Priority to CA002245617A priority patent/CA2245617C/en
Priority to SI9730223T priority patent/SI0892636T1/xx
Priority to US09/117,728 priority patent/US6056950A/en
Priority to AT97902574T priority patent/ATE204745T1/de
Publication of ITRM960075A1 publication Critical patent/ITRM960075A1/it
Application granted granted Critical
Publication of IT1283911B1 publication Critical patent/IT1283911B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT96RM000075A 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo IT1283911B1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT96RM000075A IT1283911B1 (it) 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
JP52835697A JP3872515B2 (ja) 1996-02-05 1997-02-04 タマリンド種子多糖で粘稠化された点眼液
EP97902574A EP0892636B1 (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
PT97902574T PT892636E (pt) 1996-02-05 1997-02-04 Solucoesoftalmicas tornadas viscosas com polissacarido de semente de tamarindo
DE69706410T DE69706410T2 (de) 1996-02-05 1997-02-04 Mit tamarindensamenpolysacchariden verdickte opthalmische lösungen
ES97902574T ES2164327T3 (es) 1996-02-05 1997-02-04 Soluciones oftalmicas hechas viscosas mediante polisacarido procedente de semillas de tamarindo.
PCT/IT1997/000026 WO1997028787A1 (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
AU16178/97A AU1617897A (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
DK97902574T DK0892636T3 (da) 1996-02-05 1997-02-04 Med tamarindfrøpolysaccharider fortykkede ophthalmiske opløsninger
KR10-1998-0705973A KR100430260B1 (ko) 1996-02-05 1997-02-04 타마린드씨폴리사카라이드로점성을제공한안약
EA199800689A EA001067B1 (ru) 1996-02-05 1997-02-04 Офтальмологические растворы, загущенные с помощью полисахаридов семян тамаринда
CA002245617A CA2245617C (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
SI9730223T SI0892636T1 (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
US09/117,728 US6056950A (en) 1996-02-05 1997-02-04 Ophthalmic solutions viscosified with tamarind seed polysaccharide
AT97902574T ATE204745T1 (de) 1996-02-05 1997-02-04 Mit tamarindensamenpolysacchariden verdickte opthalmische lösungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000075A IT1283911B1 (it) 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo

Publications (3)

Publication Number Publication Date
ITRM960075A0 ITRM960075A0 (it) 1996-02-05
ITRM960075A1 ITRM960075A1 (it) 1997-08-05
IT1283911B1 true IT1283911B1 (it) 1998-05-07

Family

ID=11403863

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000075A IT1283911B1 (it) 1996-02-05 1996-02-05 Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo

Country Status (14)

Country Link
US (1) US6056950A (it)
EP (1) EP0892636B1 (it)
JP (1) JP3872515B2 (it)
KR (1) KR100430260B1 (it)
AT (1) ATE204745T1 (it)
AU (1) AU1617897A (it)
CA (1) CA2245617C (it)
DE (1) DE69706410T2 (it)
DK (1) DK0892636T3 (it)
EA (1) EA001067B1 (it)
ES (1) ES2164327T3 (it)
IT (1) IT1283911B1 (it)
PT (1) PT892636E (it)
WO (1) WO1997028787A1 (it)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291892B1 (it) * 1997-04-24 1999-01-21 Alessandro Lambiase Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella
PT999825E (pt) 1997-07-29 2004-02-27 Alcon Lab Inc Composicoes oftalmicas contendo polimeros de galactomanano e borato
IT1305294B1 (it) 1999-01-29 2001-05-04 Alessandro Lambiase Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
JP2002538124A (ja) 1999-03-01 2002-11-12 ヴィスタ サイエンティフィック エルエルシー ムチンを含む眼科用調合物
WO2002049611A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic lubricating solution adapted for use in lasik surgery
WO2002049610A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
ES2314049T3 (es) * 2001-02-15 2009-03-16 Access Pharmaceuticals, Inc. Formulaciones liquidas para la prevencion y el tratamiento de enfermedades y trastornos de la mucosa.
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6465506B2 (en) * 2001-02-22 2002-10-15 Ophthalmic Research Associates, Inc. Instillation techniques for ophthalmic agents to enhance treatment effect
CA2447383A1 (en) 2001-06-29 2003-01-09 Biovitrum Ab Process for bulk autoclaving
CA2456833A1 (en) * 2001-08-10 2003-02-20 Masahiro Inohara Polysaccharide-containing compositions and use thereof
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
EP2130541A3 (en) 2002-07-29 2013-12-18 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
SI1663242T1 (sl) 2003-08-07 2011-09-30 Rigel Pharmaceuticals Inc 2,4-pirimidindiaminske spojine in uporabe kot antiproliferativna sredstva
AU2004263149B2 (en) * 2003-08-07 2010-08-19 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using same
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
KR20060121151A (ko) * 2003-11-10 2006-11-28 도레이 가부시끼가이샤 다당류 함유 조성물 및 누액층 안정화 점안제
US20050210732A1 (en) * 2004-03-26 2005-09-29 Guerin John W Crank bait tail
JP4395016B2 (ja) * 2004-06-29 2010-01-06 日清オイリオグループ株式会社 ゲル状吸水用組成物
ATE429209T1 (de) * 2005-02-09 2009-05-15 Safilens S R L Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
EP1698630B1 (en) 2005-03-03 2014-09-03 ALFA WASSERMANN S.p.A. New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ITRM20050447A1 (it) * 2005-08-19 2007-02-20 Anabasis S R L Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson.
ES2622493T3 (es) 2006-02-24 2017-07-06 Rigel Pharmaceuticals, Inc. Composiciones y métodos para la inhibición de la ruta de JAK
JP5134778B2 (ja) * 2006-03-10 2013-01-30 日清オイリオグループ株式会社 ゲル組成物及び該ゲル組成物を使用したパック化粧料
JP5264759B2 (ja) 2006-11-21 2013-08-14 ライジェル ファーマシューティカルズ， インコーポレイテッド ２，４−ピリミジンジアミン化合物のプロドラッグ塩およびそれらの使用
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
GB0719969D0 (en) 2007-10-12 2007-11-21 Cambridge Entpr Ltd Substance monitoring and control in human or animal bodies
AU2008350907A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
JP5815411B2 (ja) 2008-12-30 2015-11-17 ライジェル ファーマシューティカルズ， インコーポレイテッド ピリミジンジアミンキナーゼ阻害剤
EP2389372B1 (en) 2009-01-23 2015-09-09 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
WO2010091198A1 (en) 2009-02-06 2010-08-12 University Of Southern California Therapeutic compositions comprising monoterpenes
RU2557982C2 (ru) 2009-07-28 2015-07-27 Райджел Фармасьютикалз, Инк. Композиции и способы ингибирования пути jak
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
US8507734B2 (en) 2010-03-03 2013-08-13 Neonc Technologies Inc. Pharmaceutical compositions comprising monoterpenes
CA2837400C (en) 2010-04-24 2017-12-12 Viamet Pharmaceuticals, Inc. 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
HUE034519T2 (en) 2010-05-24 2018-02-28 Indena Spa Tamarindus seed polysaccharide and ferula hermonic extract for use in the treatment of inflammatory diseases
MX341220B (es) * 2010-05-24 2016-08-10 Indena Spa Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
JP5620168B2 (ja) * 2010-06-30 2014-11-05 Ｄｓｐ五協フード＆ケミカル株式会社 キシログルカン−カチオン複合体及びそれを含有する安定化組成物
RS54637B1 (en) * 2010-07-12 2016-08-31 Zambon S.P.A. TAMARIND SEED POLYCHARIDE POLYMER FOR USE IN DRUG Cough TREATMENT
RU2672100C2 (ru) 2010-07-28 2018-11-12 Райджел Фармасьютикалз, Инк. Композиции и способы ингибирования пути jak
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
EP3173080B1 (en) 2010-08-27 2019-12-11 Neonc Technologies Inc. Pharmaceutical compositions comprising derivatives of perillyl alcohol
AU2011320565A1 (en) 2010-10-28 2013-05-23 Innocrin Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
US8389543B2 (en) 2010-11-13 2013-03-05 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
JP6122564B2 (ja) 2010-12-17 2017-04-26 ネオンク テクノロジーズ インク． イソペリリルアルコールの使用方法および装置
CA2828360A1 (en) 2011-02-25 2012-08-30 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Chrysophaentin analogs that inhibit ftsz protein
ITMI20110583A1 (it) 2011-04-08 2012-10-09 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
RU2463022C1 (ru) * 2011-04-19 2012-10-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения больных с синдромом "сухого глаза"
CN103608028A (zh) 2011-04-28 2014-02-26 南加利福尼亚大学 人类髓源抑制性细胞癌症标记
EP2721023B1 (en) 2011-06-19 2018-08-08 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
JP6122846B2 (ja) 2011-06-19 2017-04-26 ヴィアメット ファーマスーティカルズ，インコーポレイテッド 金属酵素阻害剤化合物
CN103930418A (zh) 2011-06-23 2014-07-16 威尔金制药有限公司 金属酶抑制剂化合物
PT2741754E (pt) * 2011-08-12 2015-09-11 Zambon Spa Utilização de um polímero de polissacárido proveniente das sementes do tamarindeiro na proteção contra danos associados ao tabaco
JP6376550B2 (ja) * 2011-09-07 2018-08-22 千寿製薬株式会社 水性液剤の粘度低下抑制方法
WO2013046059A2 (en) * 2011-09-27 2013-04-04 Sykora Robert C Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
WO2013090210A1 (en) 2011-12-11 2013-06-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
PL2804858T3 (pl) 2012-01-20 2020-06-29 Mycovia Pharmaceuticals, Inc. Związki - inhibitory metaloenzymu
AU2013235729B2 (en) 2012-03-23 2017-06-01 Baylor University Compositions and methods for inhibition of cathepsins
WO2013173506A2 (en) 2012-05-16 2013-11-21 Rigel Pharmaceuticals, Inc. Method of treating muscular degradation
US20160166701A1 (en) * 2013-07-05 2016-06-16 Therakine Biodelivery Gmbh Delivery composition for topical applications and injections and ophthalmic formulations, methods for manufacturing thereof, and methods for delivery of a drug-delivery composition
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
WO2015158771A1 (en) 2014-04-15 2015-10-22 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
WO2016130800A2 (en) 2015-02-12 2016-08-18 Neonc Technologies Inc. Pharmaceutical compositions comprising perillyl alcohol derivatives
ES2705692T3 (es) 2015-06-11 2019-03-26 Novintethical Pharma Sa Composiciones nasales tópicas que contienen xiloglucanos para usar como descongestionantes
CN108135956B (zh) * 2015-07-13 2021-06-08 东北泰克诺亚奇股份有限公司 视神经保护用组合物
EP3719016A1 (en) 2015-08-04 2020-10-07 Rigel Pharmaceuticals, Inc. Benzazole compounds and methods for making and using the compounds
EP3331497B1 (en) * 2015-08-07 2021-04-14 Council of Scientific & Industrial Research A lubricant formulation of carbamoylethyl katira and a process for preparation thereof
CA3006469C (en) 2015-12-30 2023-01-10 Vps-3, Inc. Metalloenzyme inhibitor compounds
EP3475263B1 (en) 2016-06-27 2022-12-28 Rigel Pharmaceuticals, Inc. 2,4-diamino-pyrimidine compounds and their use as irak4 inhibitors
CA3041587A1 (en) 2016-10-26 2018-05-17 Rigel Pharmaceuticals, Inc. Oxazole derivatives for use as irak inhibitors and method for their preparation
US10414753B2 (en) 2016-10-26 2019-09-17 Rigel Pharmaceuticals, Inc. Amide compounds and method for making and using
JP7144411B2 (ja) 2016-11-30 2022-09-29 ネオンク テクノロジーズ インク． ペリリルアルコール－３－ブロモピルベート複合体及びがんの治療方法
RU2764666C2 (ru) 2016-12-29 2022-01-19 Селенити Терапьютикс (Бермуда), Лтд. Соединения, ингибирующие металлоферменты
EP3562306A4 (en) 2016-12-29 2020-06-24 Selenity Therapeutics (Bermuda), Ltd. METALLOENZYME INHIBITOR COMPOUNDS
WO2019006126A1 (en) 2017-06-29 2019-01-03 Rigel Pharmaceuticals, Inc. KINASE INHIBITORS AND METHODS OF MAKING AND USING THEM
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
US20210292410A1 (en) 2017-12-07 2021-09-23 Morphosys Ag Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment
WO2019157195A1 (en) 2018-02-08 2019-08-15 Neonc Technologies, Inc Methods of permeabilizing the blood brain barrier
PL3788044T3 (pl) 2018-05-03 2024-02-12 Rigel Pharmaceuticals, Inc. Związki hamujące rip1 oraz sposoby ich wytwarzania i wykorzystania
SI3788045T1 (sl) 2018-05-03 2023-07-31 Rigel Pharmaceuticals, Inc. Zaviralne spojine RIP1 in postopki njihove izdelave in uporabe
WO2020092845A1 (en) 2018-11-01 2020-05-07 Rigel Pharmaceuticals, Inc. Method and composition embodiments for treating acute myeloid leukemia
WO2020243612A1 (en) 2019-05-29 2020-12-03 Rigel Pharmaceuticals, Inc. Method of preventing and treating thrombosis
EP4009974A1 (en) 2019-08-08 2022-06-15 Rigel Pharmaceuticals, Inc. Compounds and method for treating cytokine release syndrome
CA3147444A1 (en) 2019-08-14 2021-02-18 Rigel Pharmaceuticals, Inc. Method of blocking or ameliorating cytokine release syndrome
CN114364674A (zh) 2019-08-30 2022-04-15 里格尔药品股份有限公司 吡唑化合物，其配制品以及使用所述化合物和/或配制品的方法
AU2020341681B2 (en) 2019-09-06 2024-02-15 Rigel Pharmaceuticals, Inc. RIP1 inhibitory compounds and methods for making and using the same
KR20220042206A (ko) 2019-09-06 2022-04-04 리겔 파마슈티칼스, 인크. Rip1 억제 화합물 및 그를 제조 및 사용하는 방법
EP4055021A1 (en) 2019-11-07 2022-09-14 Rigel Pharmaceuticals, Inc. Heterocyclic rip1 inhibitory compounds
WO2022187303A1 (en) 2021-03-03 2022-09-09 Rigel Pharmaceuticals, Inc. A method for treating a disease or condition using a pyrazole compound or formulation thereof
TW202300490A (zh) 2021-03-11 2023-01-01 美商雷傑製藥公司 雜環rip1激酶抑制劑
WO2023183377A1 (en) 2022-03-23 2023-09-28 Rigel Pharmaceuticals, Inc. Pyrimid-2-yl-pyrazole compounds as irak inhibitors
WO2023192479A1 (en) 2022-03-31 2023-10-05 Rigel Pharmaceuticals, Inc. Tricyclic irak inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
JPH0748278A (ja) * 1992-06-10 1995-02-21 Taiho Yakuhin Kogyo Kk 鼻腔用粉末製剤

Also Published As

Publication number Publication date
DK0892636T3 (da) 2001-12-17
AU1617897A (en) 1997-08-28
ITRM960075A1 (it) 1997-08-05
CA2245617A1 (en) 1997-08-14
ATE204745T1 (de) 2001-09-15
JP2000504685A (ja) 2000-04-18
KR100430260B1 (ko) 2004-07-30
DE69706410D1 (de) 2001-10-04
ES2164327T3 (es) 2002-02-16
CA2245617C (en) 2005-07-12
EA199800689A1 (ru) 1999-02-25
PT892636E (pt) 2002-02-28
DE69706410T2 (de) 2002-06-06
EA001067B1 (ru) 2000-10-30
US6056950A (en) 2000-05-02
WO1997028787A1 (en) 1997-08-14
JP3872515B2 (ja) 2007-01-24
ITRM960075A0 (it) 1996-02-05
EP0892636A1 (en) 1999-01-27
EP0892636B1 (en) 2001-08-29
KR19990082244A (ko) 1999-11-25

Similar Documents

Publication Publication Date Title
IT1283911B1 (it) Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
Fechner Preparation of 2% hydroxypropyl methylcellulose for viscous surgery
Toda et al. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjogren's syndrome
CA1240929A (en) Chondroitin sulfate/sodium hyaluronate compositions
AU1464995A (en) Liquid ophthalmic sustained release delivery system
ES2166905T3 (es) Composiciones que incluyen o-carboxialquilquitosano y metodos de uso en productos oftalmicos.
ATE220296T1 (de) Konfekt basierend auf hydrokolloid
ATE233083T1 (de) Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen
ATE213405T1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
MX9708043A (es) Liberacion controlada de farmacos mioticos y midriaticos en la camara anterior.
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
ATE499106T1 (de) Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure
BG104535A (en) Fluidized polymer suspensions of cationic polysaccharides in polyols and use thereof in preparing personal care compositions
MX9701609A (es) Composicion espesada por un alquileter de polisacarido.
Raimondi et al. A new viscosity enhancer for ophthalmic preparations devoid of toxicity for human conjunctival cells
ATE183384T1 (de) Lactulose-pastillen
KR960037046A (ko) 도파민 수용기 자극제를 포함하는 근시 및 녹내장 치료용 안과 제형

Legal Events

Date Code Title Description
0001 Granted